| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |